68 filings
Page 3 of 4
8-K
jk1v d7xg8
18 May 21
Regulation FD Disclosure
4:03pm
8-K
1ab320b3ahh 5t1e
17 Mar 21
Regulation FD Disclosure
7:50am
8-K
sy2 oqof0t
25 Feb 21
Regulation FD Disclosure
9:00am
8-K
zczqhp
12 Feb 21
Entry into a Material Definitive Agreement
5:13pm
8-K
bd6od
7 Jan 21
Regulation FD Disclosure
7:37am
8-K
7z1m8nfae70 8rsp
28 Dec 20
CNS Pharmaceuticals Announces Pricing of $10.0 Million Public Offering
4:30pm
8-K
xls gppmr
21 Dec 20
Other Events
9:01am
8-K
7nw61bh lsk9kr7x
11 Dec 20
Regulation FD Disclosure
8:09am
8-K
lx5hl4yu xy12u
12 Nov 20
Regulation FD Disclosure
12:00am
8-K
ynd8dswx3vbcbyj7m uv
21 Sep 20
Entry into a Material Definitive Agreement
8:03am
8-K/A
ejxe5idjk0
16 Sep 20
Regulation FD Disclosure
9:25am
8-K
nb8l7pbtd9fmf t30h
16 Sep 20
Regulation FD Disclosure
7:00am
8-K
40w ovigkxkvxelnmww
4 Sep 20
Amendment to Employment Agreement
4:30pm
8-K
3we0h f8sdwa1hfo0c
25 Jun 20
Regulation FD Disclosure
8:44am
8-K
ctaucbw3z1tyyy4zl
11 Jun 20
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
4:30pm
8-K
d281w73nhwwgzqzw u5
9 Jun 20
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
k96vtl
28 May 20
Other Events
7:00am
8-K
h3e05
27 May 20
CNS Provides Update on Development
5:15pm
8-K
m0oahia d07c539
18 May 20
CNS Announces Nasdaq Trading Halt Pending Receipt of Additional Information
5:23pm
8-K
ehtofczd4 ox0kd
26 Mar 20
Entry into a Material Definitive Agreement
4:30pm